Free tool
FAERS Monitor: Fosamax Plus D
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021762 or its brand name (Fosamax Plus D, Alendronate Sodium, Cholecalciferol). Reports on generic versions are filed under their own applications.
Reports
2,769
Serious
2,562
93% of reports
Hospitalization
1,734
Death reported
128
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- femur fracture1,410
- fall811
- osteoarthritis657
- low turnover osteopathy622
- hypertension552
- arthralgia467
- gastrooesophageal reflux disease438
- intramedullary rod insertion429
- osteoporosis428
- depression406
- anxiety404
- pain in extremity397
- back pain389
- stress fracture323
- hyperlipidaemia304
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 2 |
| 2006 | 49 |
| 2007 | 101 |
| 2008 | 218 |
| 2009 | 205 |
| 2010 | 223 |
| 2011 | 291 |
| 2012 | 772 |
| 2013 | 286 |
| 2014 | 166 |
| 2015 | 123 |
| 2016 | 72 |
| 2017 | 40 |
| 2018 | 50 |
| 2019 | 27 |
| 2020 | 24 |
| 2021 | 43 |
| 2022 | 28 |
| 2023 | 18 |
| 2024 | 13 |
| 2025 | 8 |
| 2026 | 10 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,390 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| intramedullary rod insertionSignal | 429 | 2010.8 | 1820.0 | 679,991 |
| low turnover osteopathySignal | 622 | 1400.3 | 1296.5 | 733,415 |
| stress fractureSignal | 323 | 483.6 | 434.9 | 145,832 |
| femur fractureSignal | 1,410 | 362.3 | 348.7 | 485,264 |
| hyperlipidaemiaSignal | 304 | 198.4 | 178.1 | 58,025 |
| osteoarthritisSignal | 657 | 119.5 | 111.7 | 76,059 |
| osteoporosisSignal | 428 | 79.9 | 73.2 | 32,970 |
| gastrooesophageal reflux diseaseSignal | 438 | 41.5 | 38.1 | 17,264 |
| hypertensionSignal | 552 | 19.8 | 18.4 | 9,935 |
| fallSignal | 811 | 18.6 | 17.5 | 13,633 |
| depressionSignal | 406 | 13.6 | 12.4 | 4,760 |
| back painSignal | 389 | 12.7 | 11.6 | 4,236 |
| anxietySignal | 404 | 10.8 | 9.9 | 3,625 |
| pain in extremitySignal | 397 | 10.2 | 9.4 | 3,346 |
| arthralgiaSignal | 467 | 8.5 | 7.9 | 3,160 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.